Clinical trial
A Prospective Study on the Effects of Early Dexmedetomidine Administration on Sympathetic Nervous System Activity, Pathophysiological Mechanisms, and Clinical Outcomes in Sepsis
NCT07470775 is registered in ClinicalTrials.gov with Sichuan Academy of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study on the Effects of Early Dexmedetomidine Administration on Sympathetic Nervous System Activity, Pathophysiological Mechanisms, and Clinical Outcomes in Sepsis
- Lead sponsor
- Sichuan Academy of Medical Sciences
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- March 1, 2026
- Completion date
- March 1, 2028
- Enrollment
- 168 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
sepsis, septic shock